Assessment of general health and quality of life inpatients with acne using a validated generic questionnaire

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 18, Issue 4, 2009, Pages 157-164

  Al Robaee, Ahmad A ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Acne; Quality of life; SF 36

Indexed keywords

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DEMOGRAPHY; DISEASE DURATION; EDUCATIONAL STATUS; EMOTION; FEMALE; FISHER EXACT TEST; HEALTH STATUS; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PHYSICAL CAPACITY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SOCIAL STATUS; VALIDATED GENERIC QUESTIONNAIRE;

ACNE VULGARIS; ADOLESCENT; ADULT; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 76149109444     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Krowchuck DP. Managing acne in adolescents. Ped Clin N Am. 2000;47:841-57.
2. Yazici K, Baz K, Yazici AE, Köktürk A, Tot S, Demirseren D et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004;18:435-9.
3. Parker M, Jon A, Gaynor H, Dimity P, Smith W. Psychological sequelae of acne vulgaris: Results of a qualitative study. Can Fam Physician. 2006;52(8):968-9.
4. Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L et al. Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ. 2000;163:265-71.
5. McCallum J. The SF-36 in an Australian sample: validating a new, generic health status measure. Aust J Public Health. 1995;19:160-6.
6. Ware J E, Jr. Gandek B. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998;51:903-12.
7. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcomes study: an application of methods for monitoring the results of medical care. JAMA. 1989;262:925-30.
8. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-63.
9. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-83.
10. Ware JE Jr, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res. 2001;10:405-13; discussion 415-20.
11. Gandek B, Ware JE Jr. Methods for validating and norming translations of health status questionnaires: the IQOLA project approach. J Clin Epidemiol. 1998;51:953-9.
12. Coons SJ, Alabdulmohsin SA, Draugalis JR, Hays RD. Reliability of an Arabic version of the RAND 36-item health survey and its equivalence to the US-English version. Med Care. 1998;36:428-32.
13. Abdulmohsin SA, Coons SJ, Draugalis JR, Hayss RD. Translation of the RAND 36-item survey 1.0 into Arabic. Santa Monica, CA: RAND; 1997.
14. Ware JE Jr, Kosinski M. SF-36® physical and mental health summary scales: a manual for users of version 1. 2nd ed. Lincoln, RI: Quality Metric, Inc.; 2001.
15. Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36:416-8.
16. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672-6.
17. Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol. 1997;108:103-7.